Abbott Laboratories (ABT) Short-term Investments (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Short-term Investments data on file, last reported at $492.0 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments rose 57.69% year-over-year to $492.0 million; the trailing twelve-month figure through Mar 2026 stood at $492.0 million (up 57.69% YoY), and the FY2025 full-year result was $417.0 million, up 18.8% from the prior year.
• Short-term Investments improved to $492.0 million in Q1 2026, from $417.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $492.0 million in Q1 2026 to a low of $222.0 million in Q3 2025.
• A 5-year average of $341.4 million and a median of $338.0 million in 2023 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments tumbled 36.0% in 2022 and surged 57.69% in 2026, its largest moves.
• Tracing ABT's Short-term Investments over 5 years: stood at $288.0 million in 2022, then surged by 32.99% to $383.0 million in 2023, then fell by 8.36% to $351.0 million in 2024, then grew by 18.8% to $417.0 million in 2025, then advanced by 17.99% to $492.0 million in 2026.
• Business Quant data shows ABT's Short-term Investments at $492.0 million in Q1 2026, $417.0 million in Q4 2025, and $222.0 million in Q3 2025.